Become A Featured Company

Wildflower Expands Offering, US and European Footprints

Tony Deyes

May 28th, 2019

App, Exclusive, News, Top Story

Vancouver-based Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF), which develops and designs brands focused on plant-based health and wellness products, made several recent strategic moves demonstrating its commitment to becoming a global leader in the space.

New Products

The company’s core brand started in 2012 with a mission to inspire holistic health & wellness through a range of CBD-infused products. The CBD+ Wellness line offers the natural healing properties of hemp-derived CBD with other plant-based ingredients in tinctures, capsules, vapes, and soaps, and carries a customer satisfaction guarantee.

In March, Wildflower expanded its offering with the introduction of Pure and Pure Plus tinctures formulated with hemp-derived CBD, milk thistle, and hemp seed oil to provide relief from inflammation and support healthy liver and heart function. Hemp seed oil has been added to the new offering for an optimal ratio of omega-3 and omega-6 fatty acids, and the solvent-free formulations can be taken sublingually via a dropper or added to food and beverages. Wildflower will continue to expand its CBD+ lineup, and the launch is part of the company’s ongoing product development to meet growing wholesale and retail demands for its high-quality CBD-infused health & wellness offerings.

Click here to see the company corporate presentation

William MacLean, Wildflower Brands CEO, said, “Consumers are drawn to Wildflower because of the effectiveness and range of options available in our product lineup. The strong brand loyalty of Wildflower customers reflects the time and resources invested in our pipeline of products.”

Bolstered by greater public awareness of and desire for alternative wellness products, the CBD market is the fastest-growing segment of the burgeoning cannabis market, with Brightfield Group cannabis industry analysts predicting a global market of $22 billion US by 2022, and hemp-derived CBD is forecast to be especially lucrative, the same report predicting a per annum increase of 55% over the next five years alone.

Click here to see the company corporate presentation

Wildflower received some exciting attention in February when the company’s all-natural CBD Cool Stick, designed to provide relief of muscle, joint and back pain, was selected for inclusion in this year’s ‘swag bag’ given to Academy Award nominees and presenters staying at the Four Seasons Hotel in Los Angeles, reinforcing how mainstream CBD products have become.

New York Retail Expansion

Wildflower kicked off 2019 with an expansion into New York. Wildflower products can be found in Sak’s 5th Avenue, and in over 20 health and wellness retailers in Manhattan alone. The company chose to focus on New York because of the city’s role in setting global trends, and it was obviously a prudent move, 40% of its online sales now come from the New York market.

Wildflower’s store-in-store marketing will be a place for consumers to learn about incorporating CBD into a natural, plant-based health & wellness regime, and complement its existing online and retail presence throughout the US.

Click here to see the company corporate presentation

Growing US Presence

New York has quickly become Wildflower’s largest source of online sales with California and Washington close behind.  Online sales saw 400% growth in the past 12 months and will continue to grow as online marketing programs begin this year. In Washington state, Wildflower products are sold by over 200 retailers.  In other US markets, distributed to over 150 health & wellness practitioners and stores giving Wildflower a presence in over 300 stores nationwide.

Last April, Wildflower acquired an established cannabis retailer serving the city of Los Angeles, that has all the licenses to cultivate, manufacture, distribute, retail and deliver in the State of California and the city of Los Angeles.

In 2017, the company acquired King Extracts, a California-based company focused on cannabis technology and delivery systems, best known for its King Recharge 97mm discreet rechargeable vaporizer and vape cartridges formulated with proprietary terpenes and all-natural flavours. King Extracts products are distributed in California.

Establishing a European Footprint

Wildflower recently announced its expansion into Europe’s red-hot CBD market through an agreement with Two Towers, a leading wholesale prescription medical and over-the-counter wellness distribution company in Poland and an extension of Omega Rex, a group of 14 pharmacies in the Warsaw area.

Europe’s population of over 740 million represents a potential market twice the size of the US and Canadian markets combined, a market experiencing supply shortages and still in its infancy compared to North America’s, presenting an immense opportunity for companies with the foresight to establish an early presence.

Click here to see the company corporate presentation

Wildflower has received tariff codes for the importation of its CBD+ line of products into Poland, which will then allow them to be exported to the rest of Europe.

Europe’s CBD market has vastly outpaced earlier estimated, buoyed by greater public awareness and desire for CBD-infused products which have led to a push for a more rapid liberalization of regulations across the continent. As a result, European companies are actively seeking reputable, high-quality CBD brands to fill swelling demand and attract eager consumers. With Wildflower’s CBD+ plant-based formulations in a line-up of premium wellness products, the company is well positioned to capitalize, with Two Towers helping to navigate the regulatory landscape, along with their extensive distribution network.

Commenting on the agreement, MacLean said, “The European market is fragmented with no CBD market leaders.  Our agreement with Two Towers vastly reduces barriers to moving our products between member states. This will position Wildflower as a market leader as the EU members begin opening their markets to CBD. We are excited to be working with Two Towers; their ability to expedite the regulatory process has been invaluable.”

There’s far too much to say about Wildflower than can be contained in a single article, so keep watching this page and visit https://www.wildflowerbrands.co/ for additional information.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Tony Deyes

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading